Biodesix, Inc.
BDSX
$24.00
$0.210.88%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.67% | -95.80% | 54.34% | 24.00% | -3.31% |
| Total Depreciation and Amortization | -0.28% | 2.02% | -1.42% | -2.02% | -0.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.84% | -2.03% | 11.22% | 6.27% | -28.14% |
| Change in Net Operating Assets | 157.53% | -386.66% | 162.66% | -235.50% | 393.91% |
| Cash from Operations | 84.64% | -1,406.94% | 108.76% | -35.19% | 23.65% |
| Capital Expenditure | -143.21% | 5.81% | -79.17% | 5.88% | 31.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.52% | -250.00% | 5.26% | 56.82% | 30.16% |
| Cash from Investing | -76.39% | -38.46% | -55.22% | 29.47% | 30.66% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | 80.00% | 0.00% | -25.00% | 20.00% | 28.57% |
| Issuance of Common Stock | -61.98% | 657.28% | -55.25% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 34.18% | -10.07% | -69.27% | -73.79% | 1.44% |
| Cash from Financing | -63.07% | 888.71% | -64.56% | -50.74% | 9,991.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.82% | 176.33% | 157.78% | -231.93% | 136.17% |